Suppliers, distributers, product extenders go from helper to competitor
Also: add-on pharma patents and drug prices; government policy and university research
The value of schmoozing, $3.4 trillion gone missing, the mystery of momentum investing, and more
Notable differences in death rates; it appears candidates factored in voter gender bias
Intoxication seems to work as an unofficial mitigating factor
A Chinese garment factory tidied up after golden coins were displayed
Data show growth of educated adults in city populations
Investors may underreact when information arrives in small, continuous bits
Measuring the utility of increased care and testing, inputs that aren’t always immediately available
“Uh, I already bought a house”: Tech workers spend ahead of actual stock sales
A second lever, after "surge" pricing, adjusts the supply of drivers
Hal Hershfield’s book offers research-backed methods to build a healthier, happier, more financially secure life
Homebuyers ignore warnings of rising seas; lenders keep lending
The case for using rising market volatility as a signal to pare back on stocks — does higher risk always mean higher return?
Taking a stand on controversial issues can hurt sales, but the effect is brief